SCHEMBL8487486

SCHEMBL8487486

C[S+]([O-])c1ncc2ncnc(Nc3ccc4c(c3)Cc3ccccc3-4)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 0.42
CYP1A2 P05177 2/20 0.37
ADRA2A P08913 1/20 0.37
MAOA P21397 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2C P28335 1/20 0.37
SLC6A4 P31645 1/20 0.37
HTR2B P41595 1/20 0.37
HTT P42858 2/20 0.37
HPGD P15428 2/20 0.37
ERBB2 P04626 1/20 0.37
PLK1 P53350 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483650 0.82 EGFR (0.43) EGFRCYP1A2ADRA2AMAOASLC6A2
SCHEMBL6409884 0.80 EGFR (0.62) EGFRHTTERBB2
SCHEMBL8487671 0.80 EGFR (0.44) EGFRCYP1A2ADRA2AMAOASLC6A2
SCHEMBL6993044 0.79 EGFR (0.54) EGFRCYP1A2HPGDCYP3A4MAPT
SCHEMBL6999229 0.78 EGFR (0.45) EGFRHTTHPGDERBB2MAPT
SCHEMBL6997797 0.78 EGFR (0.67) EGFRHTTERBB2
SCHEMBL6996289 0.76 KDR (0.53) EGFRHTTERBB2MAPTSMN1; SMN2
SCHEMBL6993198 0.76 EGFR (0.54) EGFRERBB2
SCHEMBL6996349 0.76 EGFR (0.48) EGFRHTTSMN1; SMN2NPC1RAB9A
SCHEMBL6993108 0.75 EGFR (0.56) EGFRHTTHPGDERBB2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed